NIH-Sponsored Trial of Lassa Vaccine Opens - Viral Hemorrhagic Disease Can be Fatal & Causes Permanent Hearing Loss ...

Reporter [email protected] If you have been hunting whitetail deer in Pennsylvania for any amount of time, you are likely familiar with the term Epizootic Hemorrhagic Disease, commonly ...

One of the standard procedures you can expect is a vitamin K shot — a safe and effective method to prevent a very serious bleeding condition that can occur in young children. Read on for more about ...

When Jessamyn Butler would get nosebleeds as a child, her mother would tell her the length of the bleed was normal, no matter ...

Gene Hackman's wife, Betsy Arakawa, died of hantavirus. What is it? What are the symptoms? Are there any cases of Georgia?

NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

Over the last several years, we have experienced an increase of large outbreaks of Crimean–Congo hemorrhagic fever virus in European countries and neighboring areas. This disease poses a great ...

A research team at Korea University's Vaccine Innovation Center (Center Director Jung Hee-jin) announced promising results in research on mRNA vaccine development to prevent hantavirus infections.In a ...

An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.

Wild animals thrive better in the wild where they have plenty of natural habitat with FWP noting it’s safer for humans to ...